We are live on ! Find out more
DCM

Diag Capital Management Portfolio holdings

AUM $87.4M
This Fund
S&P 500
This Quarter Est. Return
-15.23%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.4M
AUM Growth
–
Cap. Flow
+$93.9M
Cap. Flow %
107.42%
Top 10 Hldgs %
50.17%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$5.77M
2
ZBH icon
Zimmer Biomet
ZBH
+$5.52M
3
ATNX
Athenex, Inc. Common Stock
ATNX
+$5.46M
4
INCY icon
Incyte
INCY
+$4.69M
5
CELG
Celgene Corp
CELG
+$4.66M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.41%
2 Miscellaneous 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BAX icon
1
Baxter International
BAX
$12.8B
$5.66M 6.47%
+85,933
New +$5.77M
2018 Q4
0 quarters
ATNX
2
DELISTED
Athenex, Inc. Common Stock
ATNX
$5.45M 6.23%
+21,452
New +$5.46M
2018 Q4
0 quarters
ZBH icon
3
Zimmer Biomet
ZBH
$17.6B
$4.95M 5.66%
+49,115
New +$5.52M
2018 Q4
0 quarters
ABBV icon
4
AbbVie
ABBV
$497B
$4.65M 5.32%
+50,420
New +$4.43M
2018 Q4
0 quarters
INCY icon
5
Incyte
INCY
$22.6B
$4.59M 5.25%
+72,196
New +$4.69M
2018 Q4
0 quarters
QTRX icon
6
Quanterix
QTRX
$149M
$4.1M 4.69%
+223,949
New +$4.02M
2018 Q4
0 quarters
CELG
7
DELISTED
Celgene Corp
CELG
$4.05M 4.63%
+63,159
New +$4.66M
2018 Q4
0 quarters
AMGN icon
8
Amgen
AMGN
$226B
$3.92M 4.48%
+20,110
New +$3.92M
2018 Q4
0 quarters
MDT icon
9
Medtronic
MDT
$118B
$3.29M 3.76%
+36,180
New +$3.38M
2018 Q4
0 quarters
QTNT
10
DELISTED
Quotient Limited Ordinary Shares
QTNT
$3.23M 3.69%
+13,173
New +$3.45M
2018 Q4
0 quarters
TAK icon
11
Takeda Pharmaceutical
TAK
$59.7B
$2.98M 3.41%
+177,260
New +$2.99M
2018 Q4
0 quarters
ABT icon
12
Abbott
ABT
$176B
$2.79M 3.19%
+38,585
New +$2.71M
2018 Q4
0 quarters
ZLAB icon
13
Zai Lab
ZLAB
$2.76B
$2.79M 3.19%
+120,092
New +$2.23M
2018 Q4
0 quarters
VTRS icon
14
Viatris
VTRS
$20.1B
$2.72M 3.12%
+99,410
New +$3.22M
2018 Q4
0 quarters
PTE
15
DELISTED
PolarityTE, Inc. Common Stock
PTE
$2.47M 2.82%
+7,313
New +$2.65M
2018 Q4
0 quarters
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
$2.41M 2.76%
+397,375
New +$2.98M
2018 Q4
0 quarters
REGN icon
17
Regeneron Pharmaceuticals
REGN
$78.5B
$2.16M 2.47%
+5,792
New +$2.12M
2018 Q4
0 quarters
TEVA icon
18
Teva Pharmaceutical Industries Limited
TEVA
$48B
$2.15M 2.46%
+139,531
New +$2.86M
2018 Q4
0 quarters
AKRX
19
DELISTED
Akorn Inc
AKRX
$2.15M 2.46%
+634,046
New +$3.77M
2018 Q4
0 quarters
HAE icon
20
Haemonetics
HAE
$5.55B
$2.12M 2.43%
+21,220
New +$2.23M
2018 Q4
0 quarters
ARGX icon
21
argenx
ARGX
$51.1B
$1.61M 1.84%
+16,712
New +$1.48M
2018 Q4
0 quarters
BHVN icon
22
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.42M 1.62%
+38,319
New +$1.38M
2018 Q4
0 quarters
MMSI icon
23
Merit Medical Systems
MMSI
$5.36B
$1.4M 1.6%
+25,092
New +$1.49M
2018 Q4
0 quarters
SNY icon
24
Sanofi
SNY
$95.2B
$1.31M 1.5%
+30,240
New +$1.33M
2018 Q4
0 quarters
GWPH
25
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$1.31M 1.5%
+13,460
New +$1.77M
2018 Q4
0 quarters
1
2

Similar funds

JCP
Jabre Capital Partners Geneva, Switzerland $87.8M AUM 5.24% 1-Year Est. Return
BCEM
Bayou City Energy Management Houston, Texas $85.4M AUM
QAM
Questar Asset Management Minneapolis, Minnesota $85M AUM
7A
734 Agriculture New York $93.8M AUM 0% 1-Year Est. Return
OIMU
Orbis Investment Management (US) San Francisco, California $99.7M AUM 17.51% 1-Year Est. Return
SSP
Sapphire Star Partners Redmond, Washington $74.7M AUM 5.87% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
RCM
Rimrock Capital Management Irvine, California $71.6M AUM

Diag Capital Management's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Diag Capital Management, which disclosed 40 positions worth $87.4M. Its ten largest holdings account for 50% of the portfolio.

Its largest position is Baxter International: 85,933 shares worth $5.66M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Miscellaneous.

  • Diag Capital Management's largest Q4 2018 buy was Baxter International: 85,933 shares worth $5.66M.
  • Diag Capital Management's ten largest holdings make up 50% of its $87.4M portfolio in Q4 2018.
  • Diag Capital Management disclosed 40 positions in Q4 2018, its first 13F filing on record.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.